ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Zevra Therapeutics Inc

Zevra Therapeutics Inc (ZVRA)

4.81
0.06
(1.26%)
Closed May 05 4:00PM
4.805
-0.005
(-0.10%)
After Hours: 7:59PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
4.81
Bid
4.25
Ask
12.00
Volume
169,547
4.79 Day's Range 4.97
3.89 52 Week Range 7.28
Market Cap
Previous Close
4.75
Open
4.83
Last Trade
10
@
4.94
Last Trade Time
Financial Volume
$ 822,859
VWAP
4.8533
Average Volume (3m)
248,236
Shares Outstanding
36,218,164
Dividend Yield
-
PE Ratio
-3.78
Earnings Per Share (EPS)
-1.27
Revenue
27.46M
Net Profit
-46.05M

About Zevra Therapeutics Inc

Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Zevra Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZVRA. The last closing price for Zevra Therapeutics was $4.75. Over the last year, Zevra Therapeutics shares have traded in a share price range of $ 3.89 to $ 7.28.

Zevra Therapeutics currently has 36,218,164 shares outstanding. The market capitalization of Zevra Therapeutics is $173.85 million. Zevra Therapeutics has a price to earnings ratio (PE ratio) of -3.78.

ZVRA Latest News

Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024

CELEBRATION, Fla., May 01, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that it will host a...

Zevra Therapeutics’ President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024

CELEBRATION, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F...

Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting

The oral presentation highlighted data from Zevra’s Expanded Access Program demonstrating a consistent safety profile CELEBRATION, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics...

Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility

CELEBRATION, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that it has entered...

Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Launch of OLPRUVA® underway Topline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH symptoms Q4 2023 net revenue of $13.2M, and FY 2023 net revenue of...

US Stock Futures Stable in Pre-Market On Path for Consecutive Quarterly Gains, Oil Prices Rise

U.S. index futures are nearly unchanged in pre-market trading this Thursday. The indexes are on track to close the second consecutive quarter with positive outcomes, in addition to marking the...

Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia

KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., March 26, 2024 (GLOBE...

Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

CELEBRATION, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.296.415929203544.524.974.481382224.60009583CS
4-0.13-2.631578947374.945.074.391870254.68979995CS
12-1.18-19.69949916535.997.284.392482365.72208388CS
260.316.888888888894.57.283.892501785.55267329CS
52-0.29-5.68627450985.17.283.892285845.35756843CS
156-0.84-14.86725663725.657.283.892340345.32654721CS
260-0.84-14.86725663725.657.283.892340345.32654721CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
theorysuit theorysuit 15 seconds ago
Asked for his screenshot which he will never produce because it is all BS. CRICKETS
NWBO
1hunglo 1hunglo 44 seconds ago
Agree. Hoping best results & curative treatment for your friend to save their health & ultimately their life. One day, not in the distant future, RDGL comes to the rescue for many.
RDGL
gail gail 1 minute ago
theres no “swarming’ its very quiet here.
ALYI
Market Makers Exist Market Makers Exist 2 minutes ago
National Tobacco Co. Turning Point Brands TPB MC $578M
ILST
gail gail 2 minutes ago
im holding for much higher for now.
ALYI
Welcome2Pinkyland Welcome2Pinkyland 2 minutes ago
$EBYH for the win $$
EBYH
Inquirig Inquirig 2 minutes ago
This bozo bought between $5,.00 and $12.00 per share!!!! LOL

Perk_Idaho Free 11/29/18 12:48 PM
Post #201,281
Re: #201,272: @monentum2play - I am always amazed why would anyone short
for sure - I had to average down a long
NWBO
The Night Stalker The Night Stalker 2 minutes ago
shady
HIRU
Market Makers Exist Market Makers Exist 2 minutes ago
International Star Inc. Announces Royalty Agreement with National Tobacco for Clipper Lighters, Showcasing Ice Cube's Intellectual Property
ILST
Inquirig Inquirig 3 minutes ago
Perk_Idaho Free 11/29/18 12:48 PM
Post #201,281
Re: #201,272: @monentum2play - I am always amazed why would anyone short
for sure - I had to average down a long way, first shares I picked up were around 5.00 and I was buying on the way up. Had to buy a lot on the way down to g
NWBO
Market Makers Exist Market Makers Exist 3 minutes ago
https://www.nasdaq.com/press-release/international-star-inc.-announces-royalty-agreement-with-national-tobacco-for-clipper
ILST
StockItOut StockItOut 3 minutes ago
Your software scans only show them after they've run. Your DDAmanda doesn't show before stocks have run.
SNGX
hunterj20 hunterj20 3 minutes ago
Looks like mid to late May. They usually take a couple months, but one article said late May
AGBA
Stock_Barber Stock_Barber 5 minutes ago
Simple question:

If you do not agree with the naked short lies being told by your fellow pumpers here daily for years... WHY HAVE YOU NEVER CORRECTED THEM????

Simple question...

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fmedia.allauthor.
DBMM
DTGoody DTGoody 5 minutes ago
REPUBLICAN HIVEMIND! CONSERVATIVE AGENT DENNIS QUAID HAS A FREUDIAN SLIP ABOUT TRUMP BEING AN ACTOR!

https://youtu.be/pc7ciyaUsQE
Preciouslife1 Preciouslife1 5 minutes ago
https://www.mlb.com/news/max-muncy-has-first-career-3-home-run-game
LOVE*PINK LOVE*PINK 6 minutes ago
GROWING IT company with BILLION+ IN NAKED SHORT.

GROWING IT company
DD LINK>$DBMM now in Irvine,CA & Austin,TX
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174357234
$DBMM🔥GroundfloorInvestment🔥$GME|$AMCLevel
https://inv
AMCLEVEL DBMM GME
LOVE*PINK LOVE*PINK 6 minutes ago
GROWING IT company with BILLION+ IN NAKED SHORT.

GROWING IT company
DD LINK>$DBMM now in Irvine,CA & Austin,TX
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174357234
$DBMM🔥GroundfloorInvestment🔥$GME|$AMCLevel
https://inv
AMCLEVEL DBMM GME
Preciouslife1 Preciouslife1 7 minutes ago
https://www.mlb.com/news/shohei-ohtani-hits-two-homers-collects-four-hits-as-dodgers-sweep-braves?t=season-of-dreams-coverage
StockItOut StockItOut 7 minutes ago
You say "we." There's a team of you at DDAmanda?
SNGX
mustang656 mustang656 8 minutes ago
I like ding dong best
ABQQ
Inquirig Inquirig 9 minutes ago
🤣😂😆
NWBO
sirant sirant 10 minutes ago
Yep, it's coming!!!!!

GO $MCIC
MCIC

Your Recent History

Delayed Upgrade Clock